Insempra, a biology-powered company, completed the investment in Solena Materials, a synthetic biology company. Financial terms were not disclosed. “We are hugely excited by this investment in Solena, which will help to accelerate our market-first approach to develop superior, intrinsically sustainable ingredients. We look forward to fast-tracking Solena’s development and production of their unique synthetic proteins to develop customized, high-performance fibers for a variety of applications,” Jens Klein, Insempra Founder and CEO.